Literature DB >> 20458313

A roadmap for biomarker qualification.

David G Warnock, Carl C Peck.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 20458313     DOI: 10.1038/nbt0510-444

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  8 in total

1.  Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury.

Authors:  Yan Yu; Hong Jin; Daniel Holder; Josef S Ozer; Stephanie Villarreal; Paul Shughrue; Shu Shi; David J Figueroa; Holly Clouse; Ming Su; Nagaraja Muniappa; Sean P Troth; Wendy Bailey; John Seng; Amy G Aslamkhan; Douglas Thudium; Frank D Sistare; David L Gerhold
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

2.  Urinary clusterin, cystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury.

Authors:  Frank Dieterle; Elias Perentes; André Cordier; Daniel R Roth; Pablo Verdes; Olivier Grenet; Serafino Pantano; Pierre Moulin; Daniel Wahl; Andreas Mahl; Peter End; Frank Staedtler; François Legay; Kevin Carl; David Laurie; Salah-Dine Chibout; Jacky Vonderscher; Gérard Maurer
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

3.  Next-generation biomarkers for detecting kidney toxicity.

Authors:  Joseph V Bonventre; Vishal S Vaidya; Robert Schmouder; Peter Feig; Frank Dieterle
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

4.  A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function.

Authors:  Josef S Ozer; Frank Dieterle; Sean Troth; Elias Perentes; André Cordier; Pablo Verdes; Frank Staedtler; Andreas Mahl; Olivier Grenet; Daniel R Roth; Daniel Wahl; François Legay; Daniel Holder; Zoltan Erdos; Katerina Vlasakova; Hong Jin; Yan Yu; Nagaraja Muniappa; Tom Forest; Holly K Clouse; Spencer Reynolds; Wendy J Bailey; Douglas T Thudium; Michael J Topper; Thomas R Skopek; Joseph F Sina; Warren E Glaab; Jacky Vonderscher; Gérard Maurer; Salah-Dine Chibout; Frank D Sistare; David L Gerhold
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

5.  Towards consensus practices to qualify safety biomarkers for use in early drug development.

Authors:  Frank D Sistare; Frank Dieterle; Sean Troth; Daniel J Holder; David Gerhold; Dina Andrews-Cleavenger; William Baer; Graham Betton; Denise Bounous; Kevin Carl; Nathaniel Collins; Peter Goering; Federico Goodsaid; Yi-Zhong Gu; Valerie Guilpin; Ernie Harpur; Alita Hassan; David Jacobson-Kram; Peter Kasper; David Laurie; Beatriz Silva Lima; Romaldas Maciulaitis; William Mattes; Gérard Maurer; Leslie Ann Obert; Josef Ozer; Marisa Papaluca-Amati; Jonathan A Phillips; Mark Pinches; Matthew J Schipper; Karol L Thompson; Spiros Vamvakas; Jean-Marc Vidal; Jacky Vonderscher; Elizabeth Walker; Craig Webb; Yan Yu
Journal:  Nat Biotechnol       Date:  2010-05-10       Impact factor: 54.908

6.  Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium.

Authors:  Frank Dieterle; Frank Sistare; Federico Goodsaid; Marisa Papaluca; Josef S Ozer; Craig P Webb; William Baer; Anthony Senagore; Matthew J Schipper; Jacky Vonderscher; Stefan Sultana; David L Gerhold; Jonathan A Phillips; Gérard Maurer; Kevin Carl; David Laurie; Ernie Harpur; Manisha Sonee; Daniela Ennulat; Dan Holder; Dina Andrews-Cleavenger; Yi-Zhong Gu; Karol L Thompson; Peter L Goering; Jean-Marc Vidal; Eric Abadie; Romaldas Maciulaitis; David Jacobson-Kram; Albert F Defelice; Elizabeth A Hausner; Melanie Blank; Aliza Thompson; Patricia Harlow; Douglas Throckmorton; Shen Xiao; Nancy Xu; William Taylor; Spiros Vamvakas; Bruno Flamion; Beatriz Silva Lima; Peter Kasper; Markku Pasanen; Krishna Prasad; Sean Troth; Denise Bounous; Denise Robinson-Gravatt; Graham Betton; Myrtle A Davis; Jackie Akunda; James Eric McDuffie; Laura Suter; Leslie Obert; Magalie Guffroy; Mark Pinches; Supriya Jayadev; Eric A Blomme; Sven A Beushausen; Valérie G Barlow; Nathaniel Collins; Jeff Waring; David Honor; Sandra Snook; Jinhe Lee; Phil Rossi; Elizabeth Walker; William Mattes
Journal:  Nat Biotechnol       Date:  2010-05-10       Impact factor: 54.908

7.  The meaning and use of the area under a receiver operating characteristic (ROC) curve.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1982-04       Impact factor: 11.105

8.  Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies.

Authors:  Vishal S Vaidya; Josef S Ozer; Frank Dieterle; Fitz B Collings; Victoria Ramirez; Sean Troth; Nagaraja Muniappa; Douglas Thudium; David Gerhold; Daniel J Holder; Norma A Bobadilla; Estelle Marrer; Elias Perentes; André Cordier; Jacky Vonderscher; Gérard Maurer; Peter L Goering; Frank D Sistare; Joseph V Bonventre
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

  8 in total
  17 in total

Review 1.  Novel outcomes and end points: biomarkers in chronic obstructive pulmonary disease clinical trials.

Authors:  Prescott G Woodruff
Journal:  Proc Am Thorac Soc       Date:  2011-08

2.  Reengineering translational science: the time is right.

Authors:  Francis S Collins
Journal:  Sci Transl Med       Date:  2011-07-06       Impact factor: 17.956

Review 3.  Emerging horizons of salivary diagnostics for periodontal disease.

Authors:  L Fuentes; M Yakob; D T W Wong
Journal:  Br Dent J       Date:  2014-11       Impact factor: 1.626

4.  Fibrinogen excretion in the urine and immunoreactivity in the kidney serves as a translational biomarker for acute kidney injury.

Authors:  Dana Hoffmann; Vanesa Bijol; Aparna Krishnamoorthy; Victoria R Gonzalez; Gyorgy Frendl; Qin Zhang; Peter L Goering; Ronald P Brown; Sushrut S Waikar; Vishal S Vaidya
Journal:  Am J Pathol       Date:  2012-07-20       Impact factor: 4.307

5.  Quantitative mass spectrometry of urinary biomarkers.

Authors:  Marina Jerebtsova; Sergei Nekhai
Journal:  J Integr OMICS       Date:  2014-12-01

6.  Urinary delta-ALA: a potential biomarker of exposure and neurotoxic effect in rats co-treated with a mixture of lead, arsenic and manganese.

Authors:  Vanda Andrade; M Luísa Mateus; M Camila Batoréu; Michael Aschner; A P Marreilha dos Santos
Journal:  Neurotoxicology       Date:  2013-06-11       Impact factor: 4.294

7.  Antibody Profiling of Kawasaki Disease Using Escherichia coli Proteome Microarrays.

Authors:  Ho-Chang Kuo; Ying-Hsien Huang; Feng-Hsiang Chung; Po-Chung Chen; Tzu-Cheng Sung; Yi-Wen Chen; Kai-Sheng Hsieh; Chien-Sheng Chen; Guan-Da Syu
Journal:  Mol Cell Proteomics       Date:  2017-12-15       Impact factor: 5.911

8.  Salivary biomarkers for detection of oral squamous cell carcinoma - current state and recent advances.

Authors:  Maha Yakob; Laurel Fuentes; Marilene B Wang; Elliot Abemayor; David T W Wong
Journal:  Curr Oral Health Rep       Date:  2014-06-01

9.  Serum Neuroinflammatory Disease-Induced Central Nervous System Proteins Predict Clinical Onset of Experimental Autoimmune Encephalomyelitis.

Authors:  Itay Raphael; Johanna Webb; Francisco Gomez-Rivera; Carol A Chase Huizar; Rishein Gupta; Bernard P Arulanandam; Yufeng Wang; William E Haskins; Thomas G Forsthuber
Journal:  Front Immunol       Date:  2017-07-17       Impact factor: 7.561

10.  BRCA1 and MDM2 as independent blood-based biomarkers of head and neck cancer.

Authors:  Aditi Bhowmik; Sambuddha Das; Abhinandan Bhattacharjee; Biswadeep Choudhury; Momota Naiding; Sankar Kumar Ghosh; Yashmin Choudhury
Journal:  Tumour Biol       Date:  2016-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.